These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24565000)

  • 1. Role of C-reactive protein in schizophrenia: an overview.
    Singh B; Chaudhuri TK
    Psychiatry Res; 2014 May; 216(2):277-85. PubMed ID: 24565000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory biomarkers in psychosis and clinical high risk populations.
    Delaney S; Fallon B; Alaedini A; Yolken R; Indart A; Feng T; Wang Y; Javitt D
    Schizophr Res; 2019 Apr; 206():440-443. PubMed ID: 30414721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India.
    Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B
    Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relation between depression and inflammation].
    Fisker L; Köhler-Forsberg O; Hageman I
    Ugeskr Laeger; 2018 May; 180(20):. PubMed ID: 29761778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.
    Jacomb I; Stanton C; Vasudevan R; Powell H; O'Donnell M; Lenroot R; Bruggemann J; Balzan R; Galletly C; Liu D; Weickert CS; Weickert TW
    Front Immunol; 2018; 9():2230. PubMed ID: 30364161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.
    Misiak B; Stańczykiewicz B; Kotowicz K; Rybakowski JK; Samochowiec J; Frydecka D
    Schizophr Res; 2018 Feb; 192():16-29. PubMed ID: 28416092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia.
    Nimgaonkar VL; Dickerson F; Pouget JG; Chowdari K; O'Dushlaine C; Wood J; Klei L; Devlin B; Yolken R
    Psychiatry Res; 2018 Mar; 261():148-153. PubMed ID: 29306175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder.
    Boerrigter D; Weickert TW; Lenroot R; O'Donnell M; Galletly C; Liu D; Burgess M; Cadiz R; Jacomb I; Catts VS; Fillman SG; Weickert CS
    J Neuroinflammation; 2017 Sep; 14(1):188. PubMed ID: 28923068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.
    García-Bueno B; Bioque M; Mac-Dowell KS; Barcones MF; Martínez-Cengotitabengoa M; Pina-Camacho L; Rodríguez-Jiménez R; Sáiz PA; Castro C; Lafuente A; Santabárbara J; González-Pinto A; Parellada M; Rubio G; García-Portilla MP; Micó JA; Bernardo M; Leza JC
    Schizophr Bull; 2014 Mar; 40(2):376-87. PubMed ID: 23486748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation.
    Frydecka D; Misiak B; Pawlak-Adamska E; Karabon L; Tomkiewicz A; Sedlaczek P; Kiejna A; Beszłej JA
    Eur Arch Psychiatry Clin Neurosci; 2015 Sep; 265(6):449-59. PubMed ID: 25214388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia.
    Dickerson F; Stallings C; Origoni A; Boronow J; Yolken R
    Schizophr Res; 2007 Jul; 93(1-3):261-5. PubMed ID: 17490859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups.
    Joseph J; Depp C; Martin AS; Daly RE; Glorioso DK; Palmer BW; Jeste DV
    Schizophr Res; 2015 Oct; 168(1-2):456-60. PubMed ID: 26341579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of SNP in the CRP gene and plasma fatty acid profile in inflammatory pattern: A cross-sectional population-based study.
    Oki E; Norde MM; Carioca AA; Ikeda RE; Souza JM; Castro IA; Marchioni DM; Fisberg RM; Rogero MM
    Nutrition; 2016 Jan; 32(1):88-94. PubMed ID: 26456189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammatory profiles and their relationships with demographic, behavioural and clinical features in acute low back pain.
    Klyne DM; Barbe MF; Hodges PW
    Brain Behav Immun; 2017 Feb; 60():84-92. PubMed ID: 27720935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.
    Wium-Andersen MK; Ørsted DD; Nordestgaard BG
    Schizophr Bull; 2014 Sep; 40(5):1117-27. PubMed ID: 23996346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of high-sensitivity C-reactive protein with susceptibility to Schizophrenia in Tunisian population.
    Ayari F; Ben Chaaben A; Ben Ammar H; Nefzi R; Ouni N; Mihoub O; Abaza H; Aissa A; Douik H; Gara S; Larnaout A; Salmi A; Ben Ammar-El Gaaied A; Leboyer M; El Hechmi Z; Guemira F; Tamouza R
    Encephale; 2020 Aug; 46(4):241-247. PubMed ID: 31959465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
    Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.
    Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Bankovic D; Arsenijevic N; Lukic ML
    J Psychiatr Res; 2012 Nov; 46(11):1421-6. PubMed ID: 22974591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637.
    Kim Y; Noren Hooten N; Dluzen DF; Martindale JL; Gorospe M; Evans MK
    Mol Cell Biol; 2015 Dec; 35(24):4212-21. PubMed ID: 26438598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.